Literature DB >> 33534223

A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases.

Jennifer A Bennett1, Robert H Young2, Brooke E Howitt3, Sabrina Croce4, Pankhuri Wanjari1, Chaojie Zhen1, Arnaud Da Cruz Paula5, Emily Meserve6, J Kenneth Schoolmeester7, Sofia Westbom-Fremer8, Eduardo Benzi9, Ninad M Patil9, Loes Kooreman10, Mona El-Bahrawy11, Gian Franco Zannoni12, Thomas Krausz1, W Glenn McCluggage13, Britta Weigelt5, Lauren L Ritterhouse2, Esther Oliva2.   

Abstract

We describe 22 examples of a novel, usually paratubal, adnexal tumor associated with Peutz-Jeghers syndrome in nearly 50% of cases that harbored STK11 alterations in all tested (n=21). The patients ranged from 17 to 66 years (median=39 y) and the tumors from 4.5 to 25.5 cm (median=11 cm). Most (n=18) were paratubal, with metastases noted in 11/22 (50%) and recurrences in 12/15 (80%). Morphologically, they were characterized by interanastomosing cords and trabeculae of predominantly epithelioid cells, set in a variably prominent myxoid to focally edematous stroma, that often merged to form tubular, cystic, cribriform, and microacinar formations, reminiscent of salivary gland-type tumors. The tumor cells were uniformly atypical, often with prominent nucleoli and a variable mitotic index (median=9/10 HPFs). The tumors were usually positive to a variable extent for epithelial (CAM5.2, AE1/AE3, cytokeratin 7), sex cord (calretinin, inhibin, WT1), and mesothelial (calretinin, D2-40) markers, as well as hormone receptors. PAX8, SF1, and GATA-3 were rarely positive, while claudin-4, FOXL2, and TTF-1 were consistently negative. All sequenced tumors (n=21) harbored alterations in STK11, often with a loss of heterozygosity event. There were no other recurrently mutated genes. Recurrent copy number alterations included loss of 1p and 11q, and gain of 1q, 15q, and 15p. Despite an extensive morphologic, immunohistochemical, and molecular evaluation, we are unable to determine with certainty the histogenesis of this unique tumor. Wolffian, sex cord stromal, epithelial, and mesothelial origins were considered. We propose the term STK11 adnexal tumor to describe this novel entity and emphasize the importance of genetic counseling in these patients as a significant number of neoplasms occur in association with Peutz-Jeghers syndrome.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534223      PMCID: PMC8277663          DOI: 10.1097/PAS.0000000000001677

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.298


  53 in total

1.  Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).

Authors:  Jelena Mirkovic; Fei Dong; Lynette M Sholl; Elizabeth Garcia; Neal Lindeman; Laura MacConaill; Christopher P Crum; Marisa R Nucci; W Glenn McCluggage; Brooke E Howitt
Journal:  Int J Gynecol Pathol       Date:  2019-11       Impact factor: 2.762

2.  Endometrioid carcinoma of the fallopian tube resembling an adnexal tumor of probable wolffian origin: a report of six cases.

Authors:  D Daya; R H Young; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1992       Impact factor: 2.762

Review 3.  Differential diagnosis of ovarian tumors based primarily on their patterns and cell types.

Authors:  R H Young; R E Scully
Journal:  Semin Diagn Pathol       Date:  2001-08       Impact factor: 3.464

4.  Peutz-Jeghers syndrome associated with precocious puberty.

Authors:  H M Solh; R S Azoury; S S Najjar
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

5.  Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.

Authors:  Radhika Theresa Tandon; Yuis Jimenez-Cortez; Robert Taub; Alain C Borczuk
Journal:  Arch Pathol Lab Med       Date:  2017-10-19       Impact factor: 5.534

6.  Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

Authors:  Marco Lo Iacono; Valentina Monica; Luisella Righi; Federica Grosso; Roberta Libener; Simona Vatrano; Paolo Bironzo; Silvia Novello; Loredana Musmeci; Marco Volante; Mauro Papotti; Giorgio V Scagliotti
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

7.  Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases.

Authors:  R H Young; G R Dickersin; R E Scully
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

8.  Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix.

Authors:  R H Young; W R Welch; G R Dickersin; R E Scully
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

9.  Accelerating Discovery of Functional Mutant Alleles in Cancer.

Authors:  Matthew T Chang; Tripti Shrestha Bhattarai; Alison M Schram; Craig M Bielski; Mark T A Donoghue; Philip Jonsson; Debyani Chakravarty; Sarah Phillips; Cyriac Kandoth; Alexander Penson; Alexander Gorelick; Tambudzai Shamu; Swati Patel; Christopher Harris; JianJiong Gao; Selcuk Onur Sumer; Ritika Kundra; Pedram Razavi; Bob T Li; Dalicia N Reales; Nicholas D Socci; Gowtham Jayakumaran; Ahmet Zehir; Ryma Benayed; Maria E Arcila; Sarat Chandarlapaty; Marc Ladanyi; Nikolaus Schultz; José Baselga; Michael F Berger; Neal Rosen; David B Solit; David M Hyman; Barry S Taylor
Journal:  Cancer Discov       Date:  2017-12-15       Impact factor: 39.397

10.  Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.

Authors:  Sarah H Kim; Arnaud Da Cruz Paula; Thais Basili; Higinio Dopeso; Rui Bi; Fresia Pareja; Edaise M da Silva; Rodrigo Gularte-Mérida; Zhen Sun; Sho Fujisawa; Caitlin G Smith; Lorenzo Ferrando; Ana Paula Martins Sebastião; Yonina Bykov; Anqi Li; Catarina Silveira; Charles W Ashley; Anthe Stylianou; Pier Selenica; Wesley R Samore; Achim A Jungbluth; Dmitriy Zamarin; Nadeem R Abu-Rustum; Kristian Helin; Robert A Soslow; Jorge S Reis-Filho; Esther Oliva; Britta Weigelt
Journal:  Nat Commun       Date:  2020-01-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.